Since its inception in 2006, UNITAID has made a significant contribution to the fight against HIV/AIDS, TB and malaria. UNITAID quickly got off to a strong start in pursuit of its mission to play a distinctive market-shaping role in market niches critical to the fight against the three diseases.
UNITAID has provided funding to implementing partners to carry out nearly two-dozen projects and has committed US$1.5 billion. By far the largest share of the funding has been raised by UNITAID through the innovative air ticket levy, a pioneering innovative financing mechanism, and this funding has been supplemented by traditional donor contributions.
This funding has supported a series of projects that have achieved impressive market and public health outcomes. There are strong indications that many of these projects achieve better outcomes than those of traditional investments in public health service delivery because of a multiplier effect. UNITAID’s contribution, in this respect, is particularly important in the context of challenging economic conditions in which many low income countries as well as donor countries are facing significant fiscal pressures.
Download the full Summary to read more.
